Tag: FDA

Transvaginal Mesh Settlement Information

Transvaginal Mesh Risk Label May Be Heightened by FDA

In the wake of mounting lawsuits against manufacturers of transvaginal mesh devices implanted in women to treat a litany of internal conditions, the U.S. Food and Drug Administration ("FDA") is now moving to heighten the risk[...]


Underreported Da Vinci Robot Injuries Lead to More Injured Patients

Underreporting of da Vinci robotic surgeries may be contributing to increased incidence of injury to patients who elect the robotic procedures lacking an accurate understanding of inherent risks. Bloomberg recently published an unsettling news story recently[...]

FDA Social Media Issues

FDA Grapples With Social Media

As businesses continue to capitalize on social media as an inexpensive and effective advertising tool, pharmaceutical companies are struggling to find ways to embrace this trend while abiding by FDA regulations, “…fear of offending the FDA[...]